Bone and soft tissue sarcomas, tumors of the skinBone and soft tissue sarcomas, tumors of the skinСаркомы костей, мягких тканей и опухоли кожи2219-46142782-3687Publishing House ABV Press484SOFT TISSUE SARCOMASСАРКОМЫ МЯГКИХ ТКАНЕЙGastrointestinal stromal tumor. Diagnostic advantages of radiology and endoscopic methodsГастроинтестинальные стромальные опухоли. Диагностические возможности лучевых и эндоскопических методовTsymzhitovaN. T.ЦымжитоваН. Ц.
Russian Federation

Moscow

г. Москва

natsym@yandex.ruDolgushinB. I.ДолгушинБ. И.
Russian Federation

Moscow

г. Москва

StilidiI. S.СтилидиИ. С.
Russian Federation

Moscow

г. Москва

MedvedevaB. M.МедведеваБ. М.
Russian Federation

Moscow

г. Москва

FilonenkoD. A.ФилоненкоД. А.
Russian Federation

Moscow

г. Москва

FGBU N.N. Blokhin Russian Cancer Research CenterФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН270120146153552701202227012022Copyright ©; 2014, Tsymzhitova N.T., Dolgushin B.I., Stilidi I.S., Medvedeva B.M., Filonenko D.A.Copyright ©; 2014, Цымжитова Н.Ц., Долгушин Б.И., Стилиди И.С., Медведева Б.М., Филоненко Д.А.2014Tsymzhitova N.T., Dolgushin B.I., Stilidi I.S., Medvedeva B.M., Filonenko D.A.Цымжитова Н.Ц., Долгушин Б.И., Стилиди И.С., Медведева Б.М., Филоненко Д.А.https://creativecommons.org/licenses/by/4.0https://sarbon.abvpress.ru/jour/article/view/484

Determination of the advantages (sensitivity, specificity) combining radiology imaging modalities and endoscopy studies in detection of gastrointestinal stromal tumor.

Представлены данные возможностей (чувствительность, специфичность) лучевых и эндоскопических методов (РИ, ЭИ, ЭУС, УЗТ, РКТ, МРТ, АГ) и их комбинации в выявлении гастроинтестинальных стромальных опухолей.

gastrointestinal stromal tumorradiology and endoscopic methodsгастроинтестинальные стромальные опухолиметоды лучевой и эндоскопической диагностики1. De Matteo R.P., Heinrich M.C., EL-Rifai W.M. Clinicai management of gastrointestinal stromal tumors: before and after STI- 57. Hum. Patho.1999, v. 30, p. 1213-1220.De Matteo R.P., Heinrich M.C., EL-Rifai W.M. Clinicai management of gastrointestinal stromal tumors: before and after STI- 57. Hum. Patho.1999, v. 30, p. 1213-1220.2. Fletcher C.D., Berman J.J., Corless C. et al. Diagnosis of gastrointestinal stromal tumors: а consensus approach. Hum. Patol. 2002, v. 33, p. 459-465.Fletcher C.D., Berman J.J., Corless C. et al. Diagnosis of gastrointestinal stromal tumors: а consensus approach. Hum. Patol. 2002, v. 33, p. 459-465.3. Miettinem M., Lasota J. Gastrointestinal stromal tumors definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001, v. 438, p. 1-12.Miettinem M., Lasota J. Gastrointestinal stromal tumors definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001, v. 438, p. 1-12.4. Miettinen M., Lasotа J. Gastrointestinal Stromal Tumors (review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch. Pathol. Lab. Med. 2006, p. 130.Miettinen M., Lasotа J. Gastrointestinal Stromal Tumors (review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch. Pathol. Lab. Med. 2006, p. 130.5. Lasota J., Jasinski M., Sarlomo-Rikala M. l. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 1999, v. 154, p. 53-60.Lasota J., Jasinski M., Sarlomo-Rikala M. l. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 1999, v. 154, p. 53-60.6. Gupta M., Sheppard B.C., Corless C.L. Outcome following surgical therapy for gastrointestinal stromal tumors. J. Gastrointest. Surg. 2006, p. 1099-1105.Gupta M., Sheppard B.C., Corless C.L. Outcome following surgical therapy for gastrointestinal stromal tumors. J. Gastrointest. Surg. 2006, p. 1099-1105.7. Demetri G.D., von Mehren M., Blanke C.D.N. Efficacy and safety of imatinibmesylate in advanced gastrointestinal stromal tumors. Engl. J. Med. 2002, v. 347, p. 472-480.Demetri G.D., von Mehren M., Blanke C.D.N. Efficacy and safety of imatinibmesylate in advanced gastrointestinal stromal tumors. Engl. J. Med. 2002, v. 347, p. 472-480.8. Eisenberg B.L., Harris J., Blanke C.D. et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumour (GIST): Early results of RTOG 0132/ACRIN 6665. J. Surg. Oncol. 2009, v. 99, p. 42-47.Eisenberg B.L., Harris J., Blanke C.D. et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumour (GIST): Early results of RTOG 0132/ACRIN 6665. J. Surg. Oncol. 2009, v. 99, p. 42-47.9. Ando N., Goto H., Niwa Y. et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest. Endosc. 2002, v. 55, p. 37-43.Ando N., Goto H., Niwa Y. et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest. Endosc. 2002, v. 55, p. 37-43.10. Connolly E.M., Gaffney E., Reynolds J.V. Gastrointestinal stromal tumors. Br. J. Surg. 2003, v. 90, p. 1178-1186.Connolly E.M., Gaffney E., Reynolds J.V. Gastrointestinal stromal tumors. Br. J. Surg. 2003, v. 90, p. 1178-1186.